article thumbnail

Small RNA as a central player in infections

Scienmag

Credit: (Image: Chair of Molecular Infection Biology II / University of Wuerzburg / SCIGRAPHIX) More than half of the world’s population carries the bacterium Helicobacter pylori in their stomach mucosa.

RNA 93
article thumbnail

Study shows why some people may become seriously ill from meningococcal bacteria

Scienmag

Credit: Francesco Righetti Researchers at Karolinska Institutet in Sweden have come one step closer toward understanding why some people become seriously ill or die from a common bacterium that leaves most people unharmed.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Scientists discover small RNA that regulates bacterial infection

The Pharma Data

Scientists discover small RNA that regulates bacterial infection People with weakened immune systems are at constant risk of infection. Interestingly, the researchers found that rather than encoding a protein, the gene encodes a small RNA that plays a vital role in bacterial respiration. aeruginosa infections. Source link: [link]

RNA 40
article thumbnail

2020 Year in Review: COVID-19, CRISPR and Immunotherapies Define the Year for the Life Sciences

XTalks

When a virus infects bacteria (these viruses are called bacteriophages), parts of its genetic material can get incorporated into the genome of the bacterium as sequences called clustered regularly interspaced short palindromic repeats (CRISPR). Single-Cell RNA Sequencing.

article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

2) Veklury (remdesivir) Veklury, approved by the FDA in 2020, is a SARS-CoV-2 nucleotide analog RNA polymerase inhibitor designed for the treatment of COVID-19. Moderna, a pharma and biotech company based in Massachusetts, specializes in RNA therapeutics, particularly mRNA vaccines. Veklury generated a revenue of $3.91 billion in 2022.

Sales 98